Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $866 - $1,002
24 Added 0.25%
9,778 $359,000
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $118 - $153
3 Added 0.03%
9,754 $398,000
Q4 2022

Feb 02, 2023

SELL
$41.75 - $54.5 $8,391 - $10,954
-201 Reduced 2.02%
9,751 $500,000
Q3 2022

Nov 04, 2022

BUY
$43.76 - $53.42 $131 - $160
3 Added 0.03%
9,952 $435,000
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $139 - $165
3 Added 0.03%
9,949 $522,000
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $9,333 - $11,564
-204 Reduced 2.01%
9,946 $515,000
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $5,536 - $8,207
-134 Reduced 1.3%
10,150 $599,000
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $1,256 - $1,613
32 Added 0.31%
10,284 $442,000
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $12,604 - $14,278
351 Added 3.55%
10,252 $401,000
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $21,266 - $23,983
635 Added 6.85%
9,901 $359,000
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $9,505 - $12,087
284 Added 3.16%
9,266 $341,000
Q3 2020

Nov 02, 2020

SELL
$31.75 - $37.25 $142,716 - $167,438
-4,495 Reduced 33.35%
8,982 $330,000
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $19,186 - $23,275
637 Added 4.96%
13,477 $441,000
Q1 2020

May 19, 2020

BUY
$27.03 - $38.62 $70,818 - $101,184
2,620 Added 25.64%
12,840 $419,000
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $13,266 - $15,056
403 Added 4.11%
10,220 $400,000
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $93,928 - $121,797
2,891 Added 41.74%
9,817 $353,000
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $256,123 - $287,567
6,926 New
6,926 $300,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track X Square Capital, LLC Portfolio

Follow X Square Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of X Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on X Square Capital, LLC with notifications on news.